OTX008 : Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Mubritinib :Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells
EPZ005687 : Targeting EZH2 in cancer
Elexacaftor :Therapie der Mukoviszidose – neue Medikamente geben Hoffnung
Pyrvinium: Inhibitory effect of the anthelmintic drug pyrvinium pamoate on T315I BCR‑ABL‑positive CML cells
Oltipraz: Nrf2 activators as potential modulators of injury in human kidney cells